Clopidogrel Tablets
Utilized in myocardial infarction indicated to mitigate cardiovascular events.
Strengths: 75mg
Where to Check Availability
Medicine details
- Alternative names
Plavix
- Therapeutic class
Antiplatelet
- Pharmacological class
P2Y12 Receptor Antagonist
- Known off-label uses
atrial fibrillation
- Contraindications
active pathological bleeding; severe hepatic impairment
- Precautions and warnings
stop treatment prior to surgery; monitor for unexplained bleeding
- Minor side effects
bruising; haematoma; epistaxis
- Moderate side effects
gastrointestinal haemorrhage; diarrhoea; abdominal pain
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
Utilized in myocardial infarction indicated to mitigate cardiovascular events.
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
2–3 hours
- Duration
24 hours
- Storage instructions
Store below 30°C in the original blister pack.
- Drug interactions
aspirin; omeprazole; warfarin
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: Use not recommended. Breastfeeding: Discontinue use.
Serious side effects
thrombotic thrombocytopenic purpura — requires immediate medical attention; agranulocytosis — requires immediate medical attention
Mechanism of action
Clopidogrel irreversibly inhibits the P2Y12 platelet adenosine diphosphate receptor, preventing platelet activation and aggregation to reduce the risk of clot formation.
Clopidogrel Tablets
Utilized in myocardial infarction indicated to mitigate cardiovascular events.
Editorial Notes
- Active ingredient(s): Clopidogrel
- Listed indication(s): Myocardial Infarction, Ischemic Stroke, Peripheral Arterial Disease
Available option
- 180 tablets - 75 mg1073-75-mg-13710